Inicio・Lista de Acciones・Embecta Corp

Embecta Corp

Cerrado

SectorSanidad

4.42 26.65

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.51

Máximo

4.68

Métricas clave
By Trading Economics
Ingresos	-48M -4.1M
Ventas	-39M 222M
P/B Media del Sector	1.928 68.51
BPA	0.27
Rentabilidad por dividendo	16.48
Margen de beneficios	-1.849
Empleados	1,850
EBITDA	-51M 45M

Recomendaciones
By TipRanks
Recomendaciones	Vender
Estimación a 12 Meses	-14.29% downside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	16.48% 2.29%
Próximas Ganancias	7 ago 2026
Fecha Próximo Dividendo	15 sept 2026
Próxima Fecha de Ex Dividendo	27 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-327M 221M
Apertura anterior	-22.23
Cierre anterior	4.42

Noticias sobre sentimiento de mercado

By Acuity

72%

28%

308 / 340 Clasificación en Healthcare

Embecta Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 ago 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 ago 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 ago 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 ago 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 jul 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 jul 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 jul 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 jul 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 jul 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 jul 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 jul 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 jul 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 jul 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Comparación entre iguales

Cambio de precio

Embecta Corp previsión

Precio Objetivo

By TipRanks

-14.29% descenso

Estimación a 12 Meses

Media 3 USD -14.29%

Máximo 3 USD

Mínimo 3 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Embecta Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

2 ratings

Comprar

Mantener

Vender

De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Embecta Corp Dist en los últimos 3 meses.

Sentimiento

By Acuity

308 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.